• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23369 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Portable ultrasound devices for obstetrical or prenatal assessment in rural or remote settings: a review of the diagnostic accuracy
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A14-14 (dimethyl fumarate)]
2014     National Institute for Health and Care Excellence (NICE) Single-incision laparoscopic cholecystectomy. NICE interventional procedures guidance 508
2014     Health Quality Ontario (HQO) Parathyroid hormone
2014     NIHR Horizon Scanning Centre (NIHR HSC) MK-5172 and MK-8742 fixed dose combination for chronic hepatitis C infection (genotypes 1, 4, 5 and 6)
2014     NIHR Health Services and Delivery Research programme Variation in compulsory psychiatric inpatient admission in England: a cross-sectional, multilevel analysis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) SmartSite bag access device: safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Tramadol for the management of pain in adult patients: clinical effectiveness and guidelines
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Fingolimod (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Telemetric adjustable pulmonary artery banding for pulmonary hypertension in infants with congenital heart defects. NICE interventional procedures guidance 505
2014     National Institute for Health and Care Excellence (NICE) VibraTip for testing vibration perception to detect diabetic peripheral neuropathy. NICE medical technologies guidance 22
2014     Health Quality Ontario (HQO) Chronic disease management systems for the treatment and management of diabetes in primary health care practices in Ontario
2014     NIHR Horizon Scanning Centre (NIHR HSC) Peginterferon lambda-1a for hepatitis C
2014     NIHR Health Services and Delivery Research programme Staff satisfaction and organisational performance: evidence from a longitudinal secondary analysis of the NHS staff survey and outcome data
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Computer-assisted interpretation of electrocardiograms: diagnostic accuracy and guidelines
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Regular exploratory examination of the need for DMP revision - a feasibility study using the example of the DMP "CHD"]
2014     National Institute for Health and Care Excellence (NICE) Insertion of an annular disc implant at lumbar discectomy. NICE interventional procedures guidance 506
2014     National Institute for Health and Care Excellence (NICE) The ReCell Spray-On Skin system for treating skin loss, scarring and depigmentation after burn injury. NICE medical technologies guidance 21
2014     Agency for Healthcare Research and Quality (AHRQ) Screening for hepatitis B virus infection in nonpregnant adolescents and adults: systematic review to update the 2004 U.S. Preventive Services Task Force Recommendation
2014     NIHR Horizon Scanning Centre (NIHR HSC) Pesky gNATs cognitive behaviour therapy for children with anxiety and low mood
2014     NIHR Health Services and Delivery Research programme Specialist rehabilitation for people with Parkinson's disease in the community: a randomised controlled trial
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Intravenous infusion pumps for transfusion of blood products: clinical effectiveness and guidelines
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Vedolizumab - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Insertion of a collagen plug to close an abdominal wall enterocutaneous fistula. NICE interventional procedures guidance 507
2014     National Institute for Health and Care Excellence (NICE) The geko device for reducing the risk of venous thromboembolism. NICE medical technologies guidance 19
2014     Health Quality Ontario (HQO) The appropriate use of neuroimaging in the diagnostic work-up of dementia: an evidence-based analysis
2014     NIHR Horizon Scanning Centre (NIHR HSC) Abaloparatide for postmenopausal osteoporosis – first and second line
2014     Blue Cross Blue Shield Association (BCBS) Quantitative electroencephalography as a diagnostic aid for attention-deficit/hyperactivity disorder in children
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Foot care for seniors in the community setting: clinical effectiveness and guidelines
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Umeclidinium/vilanterol - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Combined endoscopic and laparoscopic removal of colonic polyps. NICE interventional procedures guidance 503
2014     Health Quality Ontario (HQO) The appropriate use of neuroimaging in the diagnostic work-up of dementia: an economic literature review and cost-effectiveness analysis
2014     NIHR Horizon Scanning Centre (NIHR HSC) Idalopirdine for Alzheimer's disease as an adjunct to acetylcholinesterase inhibitor therapy
2014     Blue Cross Blue Shield Association (BCBS) Critical issues in robotic surgery
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Techniques and products for surgical hand antisepsis: a review of guidelines
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cabozantinib - Assessment according to §35a (para. 1., sentence 10) Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Total prosthetic replacement of the temporomandibular joint. NICE interventional procedures guidance 500
2014     Health Quality Ontario (HQO) Multiple intravenous infusions phase 2b: laboratory study
2014     NIHR Horizon Scanning Centre (NIHR HSC) Pimavanserin tartrate for psychosis associated with Parkinson's disease - first line
2014     Blue Cross Blue Shield Association (BCBS) Gene expression profiling in women with lymph node‒negative breast cancer to select adjuvant chemotherapy
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Obesity management interventions delivered in primary care for patients with hypertension or cardiovascular disease: a review of clinical effectiveness
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A14-19 (mirabegron)]
2014     National Institute for Health and Care Excellence (NICE) Minimally invasive video-assisted thyroidectomy. NICE interventional procedures guidance 499
2014     Health Quality Ontario (HQO) Multiple intravenous infusions phase 2a: Ontario survey
2014     NIHR Horizon Scanning Centre (NIHR HSC) Daclizumab High Yield Process for relapsing forms of multiple sclerosis – first or second line
2014     Blue Cross Blue Shield Association (BCBS) Percutaneous mitral valve repair
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Combination use of insulin and fipeptidyl peptidase-4 (DDP-4) inhibitors in Type 2 diabetes: clinical effectiveness
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A14-18 (simeprevir)]
2014     National Institute for Health and Care Excellence (NICE) Minimally invasive video-assisted parathyroidectomy. NICE interventional procedures guidance 501
2014     Health Quality Ontario (HQO) Evaluation of a chronic disease management system for the treatment and management of diabetes in primary health care practices in Ontario: an observational study
2014     Blue Cross Blue Shield Association (BCBS) Use of digital breast tomosynthesis with mammography for breast cancer screening or diagnosis
2014     NIHR Horizon Scanning Centre (NIHR HSC) Fingolimod for chronic inflammatory demyelinating polyneuropathy – second line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Retrieval and redistribution of unused home care supplies: safety, cost-effectiveness, and guidelines
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Obinituzumab - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Assessing motility of the gastrointestinal tract using a wireless capsule. NICE interventional procedures guidance 502
2014     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds
2014     Health Quality Ontario (HQO) Frequency of testing for dyslipidemia: an evidence-based analysis
2014     Blue Cross Blue Shield Association (BCBS) Artificial lumbar disc arthroplasty
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ocrelizumab for relapsing-remitting multiple sclerosis
2014     Blue Cross Blue Shield Association (BCBS) Intra-articular hyaluronic acid for osteoarthritis of the knee
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Eplerenone for NYHA functional class III/ IV heart failure and left-ventricular systolic dysfunction: clinical and cost-effectiveness
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Eribulin (new therapeutic indication) - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Endoscopic radiofrequency ablation for Barrett's oesophagus with low-grade dysplasia or no dysplasia. NICE interventional procedures guidance 496
2014     Health Quality Ontario (HQO) Frequency of testing for dyslipidemia: a systematic review and budget impact analysis
2014     Blue Cross Blue Shield Association (BCBS) CYP2D6 pharmacogenomics of tamoxifen treatment
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ocrelizumab for primary progressive multiple sclerosis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Off-label use of 5HT3 antagonists: clinical evidence and guidelines
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Empagliflozin - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Endoscopic radiofrequency ablation for squamous dysplasia of the oesophagus. NICE interventional procedures guidance 497
2014     Health Quality Ontario (HQO) Multiple intravenous infusions phases 2a and 2b: OHTAC recommendation
2014     Blue Cross Blue Shield Association (BCBS) Transcranial magnetic stimulation for depression
2014     NIHR Horizon Scanning Centre (NIHR HSC) Curelator Headache™ digital platform for adults with migraine
2014     Blue Cross Blue Shield Association (BCBS) Fecal DNA analysis for colorectal cancer screening
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Nebulized Lidocaine for patients with nasal trauma: clinical effectiveness and guidelines
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Canagliflozin/metformin - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Powered microdebrider turbinoplasty for inferior turbinate hypertrophy. NICE interventional procedures guidance 498
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Building planning and infection control: hand hygiene dispensers and individual bathrooms in residential and long-term care centres]
2014     Blue Cross Blue Shield Association (BCBS) Percutaneous tibial nerve stimulation for the treatment of voiding dysfunction
2014     NIHR Horizon Scanning Centre (NIHR HSC) SensiumVitals® vital signs monitoring patch
2014     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Fluticasone furoate/vilanterol (as trifenatate) (Relvar® Ellipta®)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Ankle braces for the prevention of injury in sport: clinical effectiveness
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Apixaban (extension of approval) - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Endoscopic saphenous vein harvest for coronary artery bypass grafting. NICE interventional procedures guidance 494
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Efficacy of neglect interventions for Indigenous children, families and communities]
2014     Blue Cross Blue Shield Association (BCBS) Gene expression analysis for prostate cancer management
2014     NIHR Horizon Scanning Centre (NIHR HSC) Peramivir for acute uncomplicated influenza in adults
2014     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Velaglucerase alfa
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Ketorolac for pain management: a review of the clinical evidence
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Nalmefene - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Radiofrequency tissue reduction for turbinate hypertrophy. NICE interventional procedures guidance 495
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Public policies for the coverage of continuous positive airway pressure devices for the treatment of obstructive sleep apnea]
2014     Blue Cross Blue Shield Association (BCBS) Myocardial sympathetic innervation imaging in heart failure
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ivacaftor (Kalydeco) for an additional 8 mutations in cystic fibrosis (licence extension)
2014     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Emtricitabine/rilpivirine/tenofovir disoproxil (as fumarate) (Eviplera®)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Cystoscopy for the diagnosis of patients with urological issues: guidelines
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ivacaftor - Assessment according to §35a (para. 1., sentence 10) Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Teriflunomide for treating relapsing–remitting multiple sclerosis. NICE technology appraisal guidance 303
2014     National Institute for Health and Care Excellence (NICE) Gastroelectrical stimulation for gastroparesis. NICE interventional procedures guidance 489
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Real-time magnetic resonance imaging (MRI)-guided radiation therapy]
2014     Blue Cross Blue Shield Association (BCBS) Artificial intervertebral disc arthroplasty for treatment of degenerative disc disease of the cervical spine